STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 55 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,945,000 | -60.2% | 1,580,000 | -36.6% | 0.31% | -54.1% |
| Q1 2019 | $12,410,000 | -3.7% | 2,492,000 | -13.4% | 0.68% | -30.5% |
| Q4 2018 | $12,893,000 | +0.3% | 2,878,000 | +8.6% | 0.98% | +26.6% |
| Q3 2018 | $12,853,000 | -0.7% | 2,650,000 | +22.8% | 0.77% | -8.7% |
| Q2 2018 | $12,948,000 | -56.6% | 2,158,000 | -36.0% | 0.85% | -62.9% |
| Q1 2018 | $29,842,000 | +43.4% | 3,372,000 | +17.5% | 2.28% | +10.0% |
| Q4 2017 | $20,808,000 | +78.0% | 2,870,000 | +69.4% | 2.08% | +50.7% |
| Q3 2017 | $11,693,000 | -3.3% | 1,694,600 | +0.2% | 1.38% | -10.7% |
| Q2 2017 | $12,098,000 | +55.3% | 1,692,000 | +3.2% | 1.54% | -4.2% |
| Q1 2017 | $7,790,000 | – | 1,640,000 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |